Must Read This!!!
15 Reasons To Invest In Cannabis Science (CBIS)
First, Cannabis Science is a very unique, one of a kind company and most importantly one of the first United States based companies that is publicly trading in the Healthcare : Biotechnology & Drugs market sector looking to produce Cannabis based medicines.
Second, with all of the new diseases/sicknesses out now, the United States and FDA are always seeking new upcoming medicines/drugs that can help cure or stabilize these diseases. CBIS is developing appropriate medicines to effectively cure/minimize the negative effects of these diseases.
Third, most importantly, CBIS is in the process of developing their own drugs for production, but CBIS has a top priority and that is to make sure that the patients are "SAFE" while using the drugs. This is what makes CBIS stand out over other drug developing companies and gives us an EDGE for the FDA trials. Cannabis Science is developing medicines that are offering MUCH LESS OF A RISK than other companies which require large doses and larger risks. This is going to give CBIS a HUGE advantage when it is time for FDA approval!
Fourth, get your foot in the door, estimated statistics show that 70% of the population have tried marijuana. The market for Cannabis based drugs has an endless potential. Cannabis Science will be a striving leader in the United States, and can likely be a mirror image of the UK based company GW pharmaceuticals. GW pharmaceuticals developed the popular drug Sativex, which is producing revenues in the millions each year. Wait until CBIS produces its final product drug, we will then be trading in the $100 per share range.
Fifth, the ongoing war in Iraq and Afghanistan will help benefit CBIS in its goal to create Cannabis based medicine to help cure/minimize the effects of Post Traumatic Stress Disorder(PTSD) patients.
Sixth, the United States economy is hurting bad right now, it would greatly benefit the United States as a whole to bring in tax revenues from Cannabis Science's medicines.
Seventh, I almost forgot this one but I just remembered!! If you guys follow the price per share every day you will notice that it is able to make QUICK ticks up or down. This is actually an advantage to shareholders because "IT WILL NOT TAKE A HUGE PRESS RELEASE" to get this thing running. Can you guys imagine what the PPS will do when the voting begins in November and the FDA trials are running?!?!? HOW CAN INVESTORS MISS OUT ON THIS?!??!
Eigth, it looks as if CBIS has a lot of support at the $0.05 range and right now it is safe to say that this is the BOTTOM for CBIS.
Ninth, Even though Cannabis Science has a deficit of $55,000,000 this can actually give CBIS an advantage in the following way... Instead of CBIS taking 7-10 years to a.ttain the appropriate funding, it seems like they are doing everything in a set time period. Why? Because Cannabis Science wants to STRIVE in this industry and right now they are way ahead of all the other companies that decide to enter into this field.
Tenth, scientific facts and evidence always win nowadays, and their sure is a lot of factual evidence about cannabis/marijuana. That is why it is great to have Dr. Melamede as the CEO of Cannabis Science. THIS GUY OBVIOUSLY KNOWS WHAT HE IS DOING. Here is a little quote I found from Dr. Melamede; "If marijuana does not promote lung cancer, that could factor into the ongoing debate over so-called medical marijuana. Melamede said he believes "marijuana has loads of medicinal value," for everything from multiple sclerosis, to the chronic pain of arthritis, to nausea caused by cancer treatment." It seems like everyone wants to start working with Dr. Melamede and his crew because they know a hell of a lot of information!
Eleventh, older people are generally the people that oppose the legalization of medical marijuana, but now they are beginning to see the great benefits and the cures it can provide!
Twelfth, the United States President Barack Obama supports the legalization of Medical Marijuana!
Thirteenth, Cannabis Science is leasing a 9,500 square foot building to do testing, research, and production in! This tells you that this company is the real deal!!!!
Fourteenth, investors can play CBIS as a short term investment or as a long term investment which would be even more rewarding!
Fifteenth, CBIS is extending internationally,"Richard Cowan, Cannabis Science CFO, added, "This move by Germany is enormously important. We have already seen significant interest in Cannabis Science in Europe and we expect that many European researchers will want to work with Dr. Melamede."
